Bringing the fundamentals into focus…
Back to Amylyx Pharmaceuticals, Inc.
How Amylyx Pharmaceuticals, Inc. stacks up
AMLX · against 287 other Healthcare companies of similar size
Profitability
13/ 100
Near the bottom of its peers.
Ranked #259 of 288 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score22 peers with a profitability score of 10–19, including AMLX · Click a bar to see the companies
Why profitability scores 13?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 95% of peers. Return on assets: -57.5% vs peer median 1.7%
- a lower return on invested capital: weaker than 90% of peers. Return on invested capital: -67.5% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = AMLX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AMLX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 278 reported | -67.5% | 7.9% | 7% | 33% | |
| Operating marginHigher is better · 265 reported | Not reported | 10.3% | — | — | 33% |
| Return on assetsHigher is better · 272 reported | -57.5% | 2.9% | 6% | 33% | |
| Return on equityHigher is better · 267 reported | -74.7% | 7.3% | 10% | Context only | |
| Gross marginHigher is better · 294 reported | 0.0% | 47.2% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around AMLX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 4 | 3.8B USD | 99 | 71 | |
| 255 | 5.4B USD | 15 | 38 | |
| 256 | 2.7B USD | 14 | 50 | |
| 256 | 2.0B USD | 14 | 26 | |
| 256 | 2.3B USD | 14 | 27 | |
| 259 | 3.7B USD | 13 | 31 | |
| 259 | 5.7B USD | 13 | 30 | |
| 259 | 3.9B USD | 13 | 52 | |
| 262 | 3.4B USD | 12 | 35 | |
| 262 | 5.1B USD | 12 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score